Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Disease Progression and CYP11B1[original query] |
|---|
| An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor. The pharmacogenomics journal 2019 Aug 19 (4): 390-400. Ravegnini Gloria, Urbini Milena, Simeon Vittorio, Genovese Chiara, Astolfi Annalisa, Nannini Margherita, Gatto Lidia, Saponara Maristella, Ianni Manuela, Indio Valentina, Brandi Giovanni, Trino Stefania, Hrelia Patrizia, Biasco Guido, Angelini Sabrina, Pantaleo Maria |
| Serum Androgen Metabolites Correlate with Clinical Variables in African and European American Men with Localized, Therapy Naïve Prostate Cancer. Metabolites 2023 2 13 (2): . Ramakrishnan Swathi, Kittles Rick A, Huss Wendy J, Wang Jianmin, Attwood Kristopher, Woloszynska An |
| A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 11 169 115890. Stefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, Esther Oomen-de Hoop, Evert de Jonge, Marieke J H Coenen, Andries M Bergman, Stijn L W Koolen, Ronald de Wit, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijss |
- Page last reviewed:Feb 1, 2024
- Content source:

